Hauz Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 09-01-2025
- Paid Up Capital ₹ 0.50 M
as on 09-01-2025
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.31 Cr
as on 09-01-2025
- Satisfied Charges ₹ 7.27 Cr
as on 09-01-2025
- Revenue 52.60%
(FY 2022)
- Profit 65.35%
(FY 2022)
- Ebitda 843.01%
(FY 2022)
- Net Worth 21.66%
(FY 2022)
- Total Assets 29.97%
(FY 2022)
About Hauz Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹14.31 Cr. The company has closed loans amounting to ₹7.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vikas Sharma and Sanjay Sinha serve as directors at the Company.
- CIN/LLPIN
U24232CH2009PTC031626
- Company No.
031626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hauz Pharma Private Limited offer?
Hauz Pharma Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Muscle Relaxant, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Respiratory System Drugs.
Who are the key members and board of directors at Hauz Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Sinha  | Managing Director | 29-May-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Sharma | Director | 01-Jun-2009 | Current |
Financial Performance of Hauz Pharma.
Hauz Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 52.6% increase. The company also saw a substantial improvement in profitability, with a 65.35% increase in profit. The company's net worth Soared by an impressive increase of 21.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hauz Pharma?
In 2021, Hauz Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanovia Biotech Private LimitedActive 8 years 3 monthsVikas Sharma and Sanjay Sinha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 22 Oct 2024 | ₹1.00 M | Open |
Canara Bank Creation Date: 02 Jul 2024 | ₹10.05 Cr | Open |
Hdfc Bank Limited Creation Date: 06 Jul 2023 | ₹3.62 Cr | Open |
How Many Employees Work at Hauz Pharma?
Unlock and access historical data on people associated with Hauz Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hauz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hauz Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
